Literature DB >> 11237810

HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis.

M R Klein1, S M Smith, A S Hammond, G S Ogg, A S King, J Vekemans, A Jaye, P T Lukey, K P McAdam.   

Abstract

Few target epitopes have been described for human CD8 T lymphocytes in antigens of Mycobacterium tuberculosis. By use of a reverse immunogenetics approach, 23 motif-bearing peptides of the Ag85 complex were tested for binding to HLA-B*35, one of the common B-types in West Africa. Three 9-mer peptides bound with high affinity to HLA-B*3501 and displayed low dissociation rates of peptide-major histocompatibility complexes (MHCs). IC(50) and half-life values of peptide-MHC class I complexes were in the same range as reported earlier for other immunogenic peptides. Immune responses against peptide Ag85C (aa 204-212) WPTLIGLAM were characterized in detail. Peptide-stimulated effector cells were able to kill macrophages infected with M. tuberculosis or bacille Calmette-Guérin. Peptide-specific CD8 T cells could be visualized by using HLA-B*3501 tetramers and were shown to produce interferon-gamma and tumor necrosis factor-alpha. Together with other published epitopes, these peptides can be used to study more closely the role of CD8 T cells in mycobacterial infection and tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237810     DOI: 10.1086/319267

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  HLA-B*35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c.

Authors:  Michèl R Klein; Abdulrahman S Hammond; Steve M Smith; Assan Jaye; Pauline T Lukey; Keith P W J McAdam
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  CD8+ T cells provide an immunologic signature of tuberculosis in young children.

Authors:  Christina Lancioni; Melissa Nyendak; Sarah Kiguli; Sarah Zalwango; Tomi Mori; Harriet Mayanja-Kizza; Stephen Balyejusa; Megan Null; Joy Baseke; Deo Mulindwa; Laura Byrd; Gwendolyn Swarbrick; Christine Scott; Denise F Johnson; LaShaunda Malone; Philipa Mudido-Musoke; W Henry Boom; David M Lewinsohn; Deborah A Lewinsohn
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

3.  HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase.

Authors:  Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 4.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

5.  Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes.

Authors:  A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

Review 6.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

7.  Identification of CD8 T-lymphocyte epitopes in OmpB of Rickettsia conorii.

Authors:  Zhen Li; C Marcela Díaz-Montero; Gustavo Valbuena; Xue-Jie Yu; Juan P Olano; Hui-Min Feng; David H Walker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  Functional insights from a comparative study on the dynamics of Antigen85 proteins and MPT51 from Mycobacterium tuberculosis.

Authors:  Shobana Sundar; David Annaraj; Anitha Selvan; Pallavi Guha Biswas; Reshma Vijayakumaran; Sharmila Anishetty
Journal:  J Mol Model       Date:  2015-11-12       Impact factor: 1.810

9.  Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.

Authors:  Roger H Brookes; Philip C Hill; Patrick K Owiafe; Hannah B Ibanga; David J Jeffries; Simon A Donkor; Helen A Fletcher; Abdulrahman S Hammond; Christian Lienhardt; Richard A Adegbola; Helen McShane; Adrian V S Hill
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

10.  Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.

Authors:  Deborah A Lewinsohn; Ervina Winata; Gwendolyn M Swarbrick; Katie E Tanner; Matthew S Cook; Megan D Null; Meghan E Cansler; Alessandro Sette; John Sidney; David M Lewinsohn
Journal:  PLoS Pathog       Date:  2007-09-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.